Paragon 28 Inc at Bank of America Global Healthcare Conference Transcript
Good afternoon. My name is Craig Bijou. I'm one of the medical device analysts here at BofA. And it's a pleasure to welcome Paragon 28. And from the company, Albert De Costa, the CEO; and Steve Deitsch, CFO. So thank you.
Questions & Answers
I want to start, you reported Q1 results last week. So I just kind of want to start it with maybe a little bit of a recap. Obviously, growth was pretty strong, 27% constant currency basis on what was a pretty tough comp in the prior year. So if you could just go into a little bit of what drove the strength in the quarter? I know you had mentioned 20% plus growth in the U.S. across all of your foot and ankle segments. But maybe I'll push you a little bit on that too and see if there's anything that stood out in the quarter, but would love to hear your view.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |